1 not yet recruiting, 1 recruiting, 1 unknown, 1 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Ketamine (Ketalar): new trials by email Literature Review of Ketamine (Ketalar) trials Research Report on Ketamine (Ketalar)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Outcomes Registry After Ketamine Infusions for Chronic Pain: A Longitudinal Evaluation Ketamine (Ketalar) - Chronic Pain, Ketamine | Not yet recruiting | Stanford University | 800 | 2026-10-01 | 2026-09-15 | |
| Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery Ketamine (Ketalar) - Pain, Postpartum Depression | Phase 1 | Recruiting | University of Utah | 50 | 2025-03-28 | 2026-10-02 |
| Intramuscular Ketamine for Suicidal Ideation Ketamine (Ketalar), Placebo - Suicidal Ideation | Phase 2 | Withdrawn | Icahn School of Medicine at Mount Sinai | 2022-02-01 | 2022-04-05 | |
| Psilocybin and Depression Psilocybin, Ketamine (Ketalar) - Severe Depression | Phase 2 | Unknown | University of Helsinki | 60 | 2018-09-01 | 2017-12-21 |
Agnosia (1) · Chronic Pain (1) · Depression (1) · Depression, Postpartum (1) · Pain (1) · Suicidal Ideation (1) · Suicide (1)
Icahn School of Medicine at Mount Sinai (1) · Stanford University (1) · University of Helsinki (1) · University of Utah (1)
United States (3)
Grace Lim, MD, MSc (1) · Matthew Klein (1)
2016 (1), R01MH134538 (1)